Skip to main content
Erschienen in: Experimental Brain Research 3/2018

01.03.2018 | Research Article

Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson’s disease

verfasst von: Julianne Stewart, Gail Bachman, Clarissa Cooper, Lianqi Liu, Sonia Ancoli-Israel, Laila Alibiglou

Erschienen in: Experimental Brain Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

In people with Parkinson’s disease (PD), anticipatory postural adjustments may be prolonged, reduced in amplitude, or absent, contributing to impaired gait initiation. In addition to motor symptoms, disturbance of the circadian rhythm (CR) is one of the common non-motor symptoms of PD. The purpose of this study was to investigate whether time of day modulates the magnitude of gait initiation impairment, and furthermore, if there is any relationship between CR dysfunction and impaired postural control in PD. Seven consecutive 24-h periods of wrist actigraphy (as a measure of CR), and then gait initiation studies (at two different times, 9:00 a.m. and 2:30 p.m., of the same day) were conducted in two cohorts of ten subjects each: people with PD, and age-matched control subjects. We found that in the PD group, the amplitude of medial/lateral center of pressure (CoP) excursions were significantly reduced in the afternoon as compared with the morning session across all trials (p < 0.05). Actigraphy results showed that CR amplitude was significantly decreased (p < 0.05) in the PD group, which suggests that the PD group suffered from CR disruption. More importantly, changes in medial/lateral CoP displacement were correlated with abnormal CR amplitude in the PD group. These findings provide novel evidence that diurnal fluctuations in treatment-resistant motor symptoms of PD, such as postural and gait initiation deficits, are associated with CR dysfunction. This study supports the idea that therapeutic correction of circadian misalignment should be considered in combination with pharmaceutical and rehabilitation treatments of motor symptoms in PD.
Literatur
Zurück zum Zitat Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S (2010) Melatonin MT1 and MT2 receptor expression in Parkinson’s disease. Med Sci Monit 16(2):BR61–BR67PubMed Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S (2010) Melatonin MT1 and MT2 receptor expression in Parkinson’s disease. Med Sci Monit 16(2):BR61–BR67PubMed
Zurück zum Zitat Alibiglou L, Videnovic A, Planetta PJ, Vaillancourt DE, MacKinnon CD (2016) Subliminal gait initiation deficits in REM sleep behavior disorder: a harbinger of freezing of gait? Mov Disord 31(11):1711–1719CrossRefPubMedPubMedCentral Alibiglou L, Videnovic A, Planetta PJ, Vaillancourt DE, MacKinnon CD (2016) Subliminal gait initiation deficits in REM sleep behavior disorder: a harbinger of freezing of gait? Mov Disord 31(11):1711–1719CrossRefPubMedPubMedCentral
Zurück zum Zitat Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26(3):342–392CrossRefPubMed Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26(3):342–392CrossRefPubMed
Zurück zum Zitat Apps MCP, Sheaff PC, Ingram DA, Kennard C, Empey DW (1985) Respiration and sleep in Parkinson’s disease. J Neurol Neurosurg Psychiatry 48:1240–1245CrossRefPubMedPubMedCentral Apps MCP, Sheaff PC, Ingram DA, Kennard C, Empey DW (1985) Respiration and sleep in Parkinson’s disease. J Neurol Neurosurg Psychiatry 48:1240–1245CrossRefPubMedPubMedCentral
Zurück zum Zitat Aston-Jones G, Bloom FE (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep–waking cycle. J Neurosci 1(8):876–886PubMed Aston-Jones G, Bloom FE (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep–waking cycle. J Neurosci 1(8):876–886PubMed
Zurück zum Zitat Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefPubMed Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefPubMed
Zurück zum Zitat Bergozoni P, Chiurulla C, Gambi D, Mennuni G, Pinto F (1975) L-dopa plus dopadecarboxylase inhibitor: sleep organization in Parkinson’s syndrome before and after treatment. Acta Neurol Belg 75:5–10 Bergozoni P, Chiurulla C, Gambi D, Mennuni G, Pinto F (1975) L-dopa plus dopadecarboxylase inhibitor: sleep organization in Parkinson’s syndrome before and after treatment. Acta Neurol Belg 75:5–10
Zurück zum Zitat Bradbury AJ, Kelly ME, Smith JA (1985) Melatonin action in the midbrain can regulate forebrain dopamine function both behaviorally and biochemically. In: Brown GM, Wainright SD (eds) Advances in the biosciences: the Pineal gland: endocrine aspects, vol 53. Pergamon Press, Oxford, pp 327–332 Bradbury AJ, Kelly ME, Smith JA (1985) Melatonin action in the midbrain can regulate forebrain dopamine function both behaviorally and biochemically. In: Brown GM, Wainright SD (eds) Advances in the biosciences: the Pineal gland: endocrine aspects, vol 53. Pergamon Press, Oxford, pp 327–332
Zurück zum Zitat Daley J, Turner R, Bliwise D, Rye D (1999) Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep 22(Suppl):S218–S219 Daley J, Turner R, Bliwise D, Rye D (1999) Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep 22(Suppl):S218–S219
Zurück zum Zitat Delval A, Tard C, Defebvre L (2014) Why we should study gait initiation in Parkinson’s disease. Neurophysiol Clin 44:69–76CrossRefPubMed Delval A, Tard C, Defebvre L (2014) Why we should study gait initiation in Parkinson’s disease. Neurophysiol Clin 44:69–76CrossRefPubMed
Zurück zum Zitat Dhawan V, Healy DG, Pal S, Chaudhuri KR (2006) Sleep-related problems of Parkinson’s disease. Age Ageing 35(3):220–228CrossRefPubMed Dhawan V, Healy DG, Pal S, Chaudhuri KR (2006) Sleep-related problems of Parkinson’s disease. Age Ageing 35(3):220–228CrossRefPubMed
Zurück zum Zitat Dzirasa K, Ribeiro S, Costa R et al (2006) Dopaminergic control of sleep–wake states. J Neurosci 26(4):10577–10589CrossRefPubMed Dzirasa K, Ribeiro S, Costa R et al (2006) Dopaminergic control of sleep–wake states. J Neurosci 26(4):10577–10589CrossRefPubMed
Zurück zum Zitat Frank JS, Horak FB, Nutt J (2000) Centrally initiated postural adjustments in parkinsonian patients on and off levodopa. J Neurophysiol 84:2440–2448CrossRefPubMed Frank JS, Horak FB, Nutt J (2000) Centrally initiated postural adjustments in parkinsonian patients on and off levodopa. J Neurophysiol 84:2440–2448CrossRefPubMed
Zurück zum Zitat Freeman A, Ciliax B, Bakay R, Daley J, Miller RD, Keating G, Levey A, Rye D (2001) Nigrostriatal collaterals to thalamus degenerate in Parkinsonian animal models. Ann Neurol 50(3):321–329CrossRefPubMed Freeman A, Ciliax B, Bakay R, Daley J, Miller RD, Keating G, Levey A, Rye D (2001) Nigrostriatal collaterals to thalamus degenerate in Parkinsonian animal models. Ann Neurol 50(3):321–329CrossRefPubMed
Zurück zum Zitat Fuller PM, Gooley JJ, Saper CB (2006) Neurobiology of the sleep–wake cycle: sleep architecture, circadian regulation, and regulatory feedback. J Biol Rhythms 21(6):482–493CrossRefPubMed Fuller PM, Gooley JJ, Saper CB (2006) Neurobiology of the sleep–wake cycle: sleep architecture, circadian regulation, and regulatory feedback. J Biol Rhythms 21(6):482–493CrossRefPubMed
Zurück zum Zitat Gantchev N, Viallet F, Aurenty R, Massion J (1996) Impairment of posturo-kinetic co-ordination during initiation of forward oriented stepping movements in parkinsonian patients. Electroencephalogr Clin Neurophysiol 101(2):110–120CrossRefPubMed Gantchev N, Viallet F, Aurenty R, Massion J (1996) Impairment of posturo-kinetic co-ordination during initiation of forward oriented stepping movements in parkinsonian patients. Electroencephalogr Clin Neurophysiol 101(2):110–120CrossRefPubMed
Zurück zum Zitat Giladi N, McMahon D, Przedborski S, Flaster E, Guillory S, Kostic V, Fahn S (1992) Motor blocks in Parkinson’s disease. Neurology 42:333–339CrossRefPubMed Giladi N, McMahon D, Przedborski S, Flaster E, Guillory S, Kostic V, Fahn S (1992) Motor blocks in Parkinson’s disease. Neurology 42:333–339CrossRefPubMed
Zurück zum Zitat Golombek DA, Rosenstein RE (2010) Physiology of circadian entrainment. Physiol Rev 90:1063–1102CrossRefPubMed Golombek DA, Rosenstein RE (2010) Physiology of circadian entrainment. Physiol Rev 90:1063–1102CrossRefPubMed
Zurück zum Zitat Grimbergen YA, Langston JW, Roos RA, Bloem BR (2009) Postural instability in Parkinson’s disease: the adrenergic hypothesis and locus coeruleus. Expert Rev Neurother 9(2):279–290CrossRefPubMed Grimbergen YA, Langston JW, Roos RA, Bloem BR (2009) Postural instability in Parkinson’s disease: the adrenergic hypothesis and locus coeruleus. Expert Rev Neurother 9(2):279–290CrossRefPubMed
Zurück zum Zitat Hall LM, Brauer SG, Horak F, Hodges PW (2013) The effect of Parkinson’s disease and Levodopa on adaptation of anticipatory postural adjustments. Neuroscience 250:483–492CrossRefPubMed Hall LM, Brauer SG, Horak F, Hodges PW (2013) The effect of Parkinson’s disease and Levodopa on adaptation of anticipatory postural adjustments. Neuroscience 250:483–492CrossRefPubMed
Zurück zum Zitat Hass CJ, Waddell DE, Fleming RP, Juncos JL, Gregor RJ (2005) Gait initiation and dynamic balance control in Parkinson’s disease. Arch Phys Med Rehabil 86:2172–2176CrossRefPubMed Hass CJ, Waddell DE, Fleming RP, Juncos JL, Gregor RJ (2005) Gait initiation and dynamic balance control in Parkinson’s disease. Arch Phys Med Rehabil 86:2172–2176CrossRefPubMed
Zurück zum Zitat Heckman CJ, Lee RH, Brownstone RM (2003) Hyperexcitable dendrites in motoneurons and their neuromodulatory control during motor behavior. Trends Neurosci 26:688–695CrossRefPubMed Heckman CJ, Lee RH, Brownstone RM (2003) Hyperexcitable dendrites in motoneurons and their neuromodulatory control during motor behavior. Trends Neurosci 26:688–695CrossRefPubMed
Zurück zum Zitat Heckman CJ, Mottram C, Quinlan K, Theiss R, Schuster J (2009) Motoneuron excitability: the importance of neuromodulatory inputs. Clin Neurophysiol 120(12):2040–2054CrossRefPubMed Heckman CJ, Mottram C, Quinlan K, Theiss R, Schuster J (2009) Motoneuron excitability: the importance of neuromodulatory inputs. Clin Neurophysiol 120(12):2040–2054CrossRefPubMed
Zurück zum Zitat Hood S, Cassidy P, Cossette MP, Weigl Y, Verwey M, Robinson B, Stewart J, Amir S (2010) Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci 30(42):14046–14058CrossRefPubMed Hood S, Cassidy P, Cossette MP, Weigl Y, Verwey M, Robinson B, Stewart J, Amir S (2010) Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci 30(42):14046–14058CrossRefPubMed
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMedPubMedCentral Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMedPubMedCentral
Zurück zum Zitat Hultborn H, Brownstone RB, Toth TI, Gossard JP (2004) Key mechanisms for setting the input–output gain across the motoneuron pool. Prog Brain Res 143:77–95PubMed Hultborn H, Brownstone RB, Toth TI, Gossard JP (2004) Key mechanisms for setting the input–output gain across the motoneuron pool. Prog Brain Res 143:77–95PubMed
Zurück zum Zitat Imbesi M, Yildiz S, Dirim Arslan A, Sharma R, Manev H, Uz T (2009) Dopamine receptor-mediated regulation of neuronal “clock” gene expression. Neuroscience 158(2):537–544CrossRefPubMed Imbesi M, Yildiz S, Dirim Arslan A, Sharma R, Manev H, Uz T (2009) Dopamine receptor-mediated regulation of neuronal “clock” gene expression. Neuroscience 158(2):537–544CrossRefPubMed
Zurück zum Zitat Inouye ST, Kawamura H (1979) Persistence of circadian rhythmicity in a mammalian hypothalamic “island” containing the suprachiasmatic nucleus. Proc Natl Acad Sci USA 76(11):5962–5966CrossRefPubMedPubMedCentral Inouye ST, Kawamura H (1979) Persistence of circadian rhythmicity in a mammalian hypothalamic “island” containing the suprachiasmatic nucleus. Proc Natl Acad Sci USA 76(11):5962–5966CrossRefPubMedPubMedCentral
Zurück zum Zitat Kales A, Ansel RD, Markham CH, Scharf MB, Tan TL (1971) Sleep in patients with Parkinson’s disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 12(2):397–407CrossRefPubMed Kales A, Ansel RD, Markham CH, Scharf MB, Tan TL (1971) Sleep in patients with Parkinson’s disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 12(2):397–407CrossRefPubMed
Zurück zum Zitat Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP (2006) Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 20(14):1868–1873CrossRefPubMedPubMedCentral Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP (2006) Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 20(14):1868–1873CrossRefPubMedPubMedCentral
Zurück zum Zitat Kudo T, Loh DH, Truong D, Wu Y, Colwell CS (2011) Circadian dysfunction in a mouse model of Parkinson’s disease. Exp Neurol 232(1):66–75CrossRefPubMed Kudo T, Loh DH, Truong D, Wu Y, Colwell CS (2011) Circadian dysfunction in a mouse model of Parkinson’s disease. Exp Neurol 232(1):66–75CrossRefPubMed
Zurück zum Zitat Kumar S, Bhatia M, Behari M (2002) Sleep disorders in Parkinson’s disease. Mov Disord 17(4):775–781CrossRefPubMed Kumar S, Bhatia M, Behari M (2002) Sleep disorders in Parkinson’s disease. Mov Disord 17(4):775–781CrossRefPubMed
Zurück zum Zitat Lauretti E, Di Meco A, Merali S, Praticò D (2017) Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson’s disease. Mol Psychiatry 22(2):280–286CrossRefPubMed Lauretti E, Di Meco A, Merali S, Praticò D (2017) Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson’s disease. Mol Psychiatry 22(2):280–286CrossRefPubMed
Zurück zum Zitat Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 11(6):512–519CrossRefPubMed Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 11(6):512–519CrossRefPubMed
Zurück zum Zitat Littner M, Kushida CA, Anderson WM et al (2003) Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 26(3):337–341CrossRefPubMed Littner M, Kushida CA, Anderson WM et al (2003) Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 26(3):337–341CrossRefPubMed
Zurück zum Zitat Lou JS (2009) Physical and mental fatigue in Parkinson’s disease: epidemiology, pathophysiology and treatment. Drugs Aging 26(3):195–208CrossRefPubMed Lou JS (2009) Physical and mental fatigue in Parkinson’s disease: epidemiology, pathophysiology and treatment. Drugs Aging 26(3):195–208CrossRefPubMed
Zurück zum Zitat MacKinnon CD, Bissig D, Chiusano J, Miller E, Rudnick L, Jager C, Zhang Y, Mille ML, Rogers MW (2007) Preparation of anticipatory postural adjustments prior to stepping. J Neurophysiol 97(6):4368–4379CrossRefPubMed MacKinnon CD, Bissig D, Chiusano J, Miller E, Rudnick L, Jager C, Zhang Y, Mille ML, Rogers MW (2007) Preparation of anticipatory postural adjustments prior to stepping. J Neurophysiol 97(6):4368–4379CrossRefPubMed
Zurück zum Zitat Marler MR, Gehrman P, Martin JL, Ancoli-Israel S (2006) The sigmoidally transformed cosine curve: a mathematical model for circadian rhythms with symmetric non-sinusoidal shapes. Stat Med 25(22):3893–3904CrossRefPubMed Marler MR, Gehrman P, Martin JL, Ancoli-Israel S (2006) The sigmoidally transformed cosine curve: a mathematical model for circadian rhythms with symmetric non-sinusoidal shapes. Stat Med 25(22):3893–3904CrossRefPubMed
Zurück zum Zitat Mille ML, Hilliard MJ, Martinez KM, Simuni T, Rogers MW (2007) Acute effects of lateral postural assist on voluntary step initiation in patients with Parkinson’s disease. Mov Disord 22(1):20–27CrossRefPubMed Mille ML, Hilliard MJ, Martinez KM, Simuni T, Rogers MW (2007) Acute effects of lateral postural assist on voluntary step initiation in patients with Parkinson’s disease. Mov Disord 22(1):20–27CrossRefPubMed
Zurück zum Zitat Miller JD, Farber J, Gatz P, Roffwarg H, German DC (1983) Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res 273(1):133–141CrossRefPubMed Miller JD, Farber J, Gatz P, Roffwarg H, German DC (1983) Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res 273(1):133–141CrossRefPubMed
Zurück zum Zitat Morris ME, Iansek R, Matyas TA, Summers JJ (1996) Stride length regulation in Parkinson’s disease. Normalization strategies and underlying mechanisms. Brain 119:551–568CrossRefPubMed Morris ME, Iansek R, Matyas TA, Summers JJ (1996) Stride length regulation in Parkinson’s disease. Normalization strategies and underlying mechanisms. Brain 119:551–568CrossRefPubMed
Zurück zum Zitat Oken BS, Salinsky MC, Elsas SM (2006) Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol 117:1885–1901CrossRefPubMedPubMedCentral Oken BS, Salinsky MC, Elsas SM (2006) Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol 117:1885–1901CrossRefPubMedPubMedCentral
Zurück zum Zitat Pahapill PA, Lozano AM (2000) The pedunculopontine nucleus and Parkinson’s disease. Brain 123(9):1767–1783CrossRefPubMed Pahapill PA, Lozano AM (2000) The pedunculopontine nucleus and Parkinson’s disease. Brain 123(9):1767–1783CrossRefPubMed
Zurück zum Zitat Pogarell O, Gasser T, van Hilten JJ, Spieker S, Pollentier S, Meier D, Oertel WH (2002) Pramipexole in patients with Parkinson’s disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study. Neurol Neurosurg Psychiatry 72:713–720CrossRef Pogarell O, Gasser T, van Hilten JJ, Spieker S, Pollentier S, Meier D, Oertel WH (2002) Pramipexole in patients with Parkinson’s disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study. Neurol Neurosurg Psychiatry 72:713–720CrossRef
Zurück zum Zitat Ralph MR, Foster RG, Davis FC, Menaker M (1990) Transplanted suprachiasmatic nucleus determines circadian period. Science 247(4945):975–978CrossRefPubMed Ralph MR, Foster RG, Davis FC, Menaker M (1990) Transplanted suprachiasmatic nucleus determines circadian period. Science 247(4945):975–978CrossRefPubMed
Zurück zum Zitat Rogers MW, Kennedy R, Palmer S, Pawar M, Reising M, Martinez KM, Simuni T, Zhang Y, MacKinnon CD (2011) Postural preparation prior to stepping in patients with Parkinson’s disease. J Neurophysiol 106(2):915–924CrossRefPubMed Rogers MW, Kennedy R, Palmer S, Pawar M, Reising M, Martinez KM, Simuni T, Zhang Y, MacKinnon CD (2011) Postural preparation prior to stepping in patients with Parkinson’s disease. J Neurophysiol 106(2):915–924CrossRefPubMed
Zurück zum Zitat Rutten S, Vriend C, van den Heuvel OA, Smit JH, Berendse HW, van der Werf YD (2012) Bright light therapy in Parkinson’s disease: an overview of the background and evidence. Parkinsons Dis 2012:767105PubMedPubMedCentral Rutten S, Vriend C, van den Heuvel OA, Smit JH, Berendse HW, van der Werf YD (2012) Bright light therapy in Parkinson’s disease: an overview of the background and evidence. Parkinsons Dis 2012:767105PubMedPubMedCentral
Zurück zum Zitat Rye DB (2004) Parkinson’s disease and RLS: the dopaminergic bridge. Sleep Med 5(3):317–328CrossRefPubMed Rye DB (2004) Parkinson’s disease and RLS: the dopaminergic bridge. Sleep Med 5(3):317–328CrossRefPubMed
Zurück zum Zitat Saper CB, Chou TC, Scammell TE (2001) The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24(12):726–731CrossRefPubMed Saper CB, Chou TC, Scammell TE (2001) The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24(12):726–731CrossRefPubMed
Zurück zum Zitat Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437(7063):1257–1263CrossRefPubMed Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437(7063):1257–1263CrossRefPubMed
Zurück zum Zitat Schrag A, Quinn N (2000) Dyskinesias and motor fluctuations in Parkinson’s disease: a community-based study. Brain 123:2297–2305CrossRefPubMed Schrag A, Quinn N (2000) Dyskinesias and motor fluctuations in Parkinson’s disease: a community-based study. Brain 123:2297–2305CrossRefPubMed
Zurück zum Zitat Steinfels GF, Heym J, Strecker RE, Jacobs BL (1983) Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res 258(2):217–228CrossRefPubMed Steinfels GF, Heym J, Strecker RE, Jacobs BL (1983) Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res 258(2):217–228CrossRefPubMed
Zurück zum Zitat Stephan FK, Zucker I (1972) Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Nat Acad Sci USA 69(6):1583–1586CrossRefPubMedPubMedCentral Stephan FK, Zucker I (1972) Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Nat Acad Sci USA 69(6):1583–1586CrossRefPubMedPubMedCentral
Zurück zum Zitat Stocchi F, Barbato L, Nordera G, Berardelli A, Ruggieri S (1998) Sleep disorders in Parkinson’s disease. J Neurol 245(S1):S15–S18CrossRefPubMed Stocchi F, Barbato L, Nordera G, Berardelli A, Ruggieri S (1998) Sleep disorders in Parkinson’s disease. J Neurol 245(S1):S15–S18CrossRefPubMed
Zurück zum Zitat Tandberg E, Larsen JP, Karlsen K (1998) A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 13(6):895–899CrossRefPubMed Tandberg E, Larsen JP, Karlsen K (1998) A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 13(6):895–899CrossRefPubMed
Zurück zum Zitat Videnovic A, Noble C, Reid KJ et al (2014) Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 71(4):463–469CrossRefPubMedPubMedCentral Videnovic A, Noble C, Reid KJ et al (2014) Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 71(4):463–469CrossRefPubMedPubMedCentral
Zurück zum Zitat Wetter TC, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 23(3):361–367CrossRefPubMed Wetter TC, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 23(3):361–367CrossRefPubMed
Zurück zum Zitat Whitehead DL, Davies AD, Playfer JR, Turnbull CJ (2008) Circadian rest-activity rhythm is altered in Parkinson’s disease patients with hallucinations. Mov Disord 23(8):1137–1145CrossRefPubMed Whitehead DL, Davies AD, Playfer JR, Turnbull CJ (2008) Circadian rest-activity rhythm is altered in Parkinson’s disease patients with hallucinations. Mov Disord 23(8):1137–1145CrossRefPubMed
Zurück zum Zitat Willis GL (2008) Parkinson’s disease as a neuroendocrine disorder of circadian function: dopamine–melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci 19(4–5):245–316PubMed Willis GL (2008) Parkinson’s disease as a neuroendocrine disorder of circadian function: dopamine–melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci 19(4–5):245–316PubMed
Zurück zum Zitat Willison LD, Kudo T, Loh DH, Kuljis D, Colwell CS (2013) Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson’s disease: insights from a transgenic mouse model. Exp Neurol 243:57–66CrossRefPubMedPubMedCentral Willison LD, Kudo T, Loh DH, Kuljis D, Colwell CS (2013) Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson’s disease: insights from a transgenic mouse model. Exp Neurol 243:57–66CrossRefPubMedPubMedCentral
Zurück zum Zitat Youngstedt SD, Kripke DF, Elliott JA, Klauber MR (2001) Circadian abnormalities in older adults. J Pineal Res 31(3):264–272CrossRefPubMed Youngstedt SD, Kripke DF, Elliott JA, Klauber MR (2001) Circadian abnormalities in older adults. J Pineal Res 31(3):264–272CrossRefPubMed
Zurück zum Zitat Zagmutt FJ, Tarrants ML (2012) Indirect comparisons of adverse events and dropout rates in early Parkinson’s disease trials of Pramipexole, Ropinirole, and Rasagiline. Int J Neurosci 122(7):345–353CrossRefPubMed Zagmutt FJ, Tarrants ML (2012) Indirect comparisons of adverse events and dropout rates in early Parkinson’s disease trials of Pramipexole, Ropinirole, and Rasagiline. Int J Neurosci 122(7):345–353CrossRefPubMed
Metadaten
Titel
Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson’s disease
verfasst von
Julianne Stewart
Gail Bachman
Clarissa Cooper
Lianqi Liu
Sonia Ancoli-Israel
Laila Alibiglou
Publikationsdatum
01.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Experimental Brain Research / Ausgabe 3/2018
Print ISSN: 0014-4819
Elektronische ISSN: 1432-1106
DOI
https://doi.org/10.1007/s00221-017-5163-5

Weitere Artikel der Ausgabe 3/2018

Experimental Brain Research 3/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.